Skip to main content

Mangafodipir use while Breastfeeding

Drugs containing Mangafodipir: Teslascan

Medically reviewed by Drugs.com. Last updated on Apr 15, 2021.

Mangafodipir Levels and Effects while Breastfeeding

Summary of Use during Lactation

Mangafodipir is a chelate of manganese that releases free manganese ions into the bloodstream after it is metabolized. Because there is no published experience with mangafodipir during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Ferumoxides, Gadopentetate

Substance Identification

Substance Name

Mangafodipir

CAS Registry Number

155319-91-8

Drug Class

  • Breast Feeding
  • Lactation
  • Contrast Media
  • Diagnostic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.